CFP, also known as properdin—activating the alternative pathway of the complement system by combining C3bBb, was also reported to have prognostic value in HCC, lung adenocarcinoma, and pancreatic adenocarcinoma.52 This evidence concerns the gene CFP and hepatocellular carcinoma.